Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes

J Rheumatol. 1994 Mar;21(3):462-6.

Abstract

Objective: To investigate the regulation of the prostaglandin (PG) synthesis by interleukin 1 (IL-1) in human synovial cells and chondrocytes.

Methods: Both cell types stimulated by human recombinant IL-1 synthesized PGE2, PGF2 alpha and 6-keto-PGF1 alpha.

Results: PGE2 was the major PG synthesized. When arachidonic acid was added exogenously at the end of the stimulation, an increase in the prostaglandin synthesis was observed after 6 and 24 h suggesting that cyclooxygenase is the limiting enzyme. Using actinomycin D and cycloheximide, PG synthesis was shown to be protein synthesis dependent. Inhibition of the constitutive cyclooxygenase by aspirin before the IL-1 stimulation confirmed that the increased prostaglandin synthesis was due to a de novo synthesis of cyclooxygenase.

Conclusion: This enzyme induction by IL-1 was found to be similar in both cell types.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acid / pharmacology
  • Aspirin / pharmacology
  • Cartilage / drug effects*
  • Cartilage / enzymology
  • Cells, Cultured
  • Cyclophosphamide / pharmacology
  • Dactinomycin / pharmacology
  • Dinoprostone / biosynthesis
  • Enzyme Induction / drug effects
  • Humans
  • Interleukin-1 / pharmacology*
  • Phospholipases A / metabolism
  • Prostaglandin-Endoperoxide Synthases / biosynthesis*
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandins / biosynthesis*
  • Protein Biosynthesis / drug effects
  • Recombinant Proteins / pharmacology
  • Synovial Membrane / drug effects*
  • Synovial Membrane / enzymology
  • Transcription, Genetic / drug effects

Substances

  • Interleukin-1
  • Prostaglandins
  • Recombinant Proteins
  • Dactinomycin
  • Arachidonic Acid
  • Cyclophosphamide
  • Prostaglandin-Endoperoxide Synthases
  • Phospholipases A
  • Dinoprostone
  • Aspirin